 | • レポートコード：MRC2312MG16350 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、75ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療機器＆消耗品 |
| Single User | ￥487,500 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥731,250 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界の組換えIII型コラーゲン市場規模と予測を収録しています。・世界の組換えIII型コラーゲン市場：売上、2018年-2023年、2024年-2029年 ・世界の組換えIII型コラーゲン市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の組換えIII型コラーゲン市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「組換えIII型コラーゲンフリーズドライファイバー」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 組換えIII型コラーゲンのグローバル主要企業は、Novus Biologicals、 Evonik Industries、 Advanced BioMatrix、 SNIME、 Shanxi Jinbo Bio-Pharmaceutical、 R&D Systems、 BAHE、 Harbin Fuerjia Technology、 Beijing Duomeikang Medical Science and Technology、 Yangzhou Meirui Biologyなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、組換えIII型コラーゲンのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の組換えIII型コラーゲン市場：タイプ別、2018年-2023年、2024年-2029年 世界の組換えIII型コラーゲン市場：タイプ別市場シェア、2022年 ・組換えIII型コラーゲンフリーズドライファイバー、組換えIII型コラーゲン複合ドレッシング、組換えIII型コラーゲンジェル、その他 世界の組換えIII型コラーゲン市場：用途別、2018年-2023年、2024年-2029年 世界の組換えIII型コラーゲン市場：用途別市場シェア、2022年 ・軟骨修復材、人工皮膚製造、膣疾患治療、傷跡予防、その他 世界の組換えIII型コラーゲン市場：地域・国別、2018年-2023年、2024年-2029年 世界の組換えIII型コラーゲン市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における組換えIII型コラーゲンのグローバル売上、2018年-2023年 ・主要企業における組換えIII型コラーゲンのグローバル売上シェア、2022年 ・主要企業における組換えIII型コラーゲンのグローバル販売量、2018年-2023年 ・主要企業における組換えIII型コラーゲンのグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Novus Biologicals、 Evonik Industries、 Advanced BioMatrix、 SNIME、 Shanxi Jinbo Bio-Pharmaceutical、 R&D Systems、 BAHE、 Harbin Fuerjia Technology、 Beijing Duomeikang Medical Science and Technology、 Yangzhou Meirui Biology ************************************************************* ・調査・分析レポートの概要 組換えIII型コラーゲン市場の定義 市場セグメント 世界の組換えIII型コラーゲン市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の組換えIII型コラーゲン市場規模 世界の組換えIII型コラーゲン市場規模：2022年 VS 2029年 世界の組換えIII型コラーゲン市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの組換えIII型コラーゲンの売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の組換えIII型コラーゲン製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：組換えIII型コラーゲンフリーズドライファイバー、組換えIII型コラーゲン複合ドレッシング、組換えIII型コラーゲンジェル、その他 組換えIII型コラーゲンのタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：軟骨修復材、人工皮膚製造、膣疾患治療、傷跡予防、その他 組換えIII型コラーゲンの用途別グローバル売上・予測 ・地域別市場分析 地域別組換えIII型コラーゲン市場規模 2022年と2029年 地域別組換えIII型コラーゲン売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Novus Biologicals、 Evonik Industries、 Advanced BioMatrix、 SNIME、 Shanxi Jinbo Bio-Pharmaceutical、 R&D Systems、 BAHE、 Harbin Fuerjia Technology、 Beijing Duomeikang Medical Science and Technology、 Yangzhou Meirui Biology ... |
This research report provides a comprehensive analysis of the Recombinant Type III Collagen market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Recombinant Type III Collagen market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Recombinant Type III Collagen, challenges faced by the industry, and potential opportunities for market players.
The global Recombinant Type III Collagen market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Recombinant Type III Collagen market presents opportunities for various stakeholders, including Cartilage Repair Materials, Artificial Skin Manufacturing. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Recombinant Type III Collagen market. Additionally, the growing consumer demand present avenues for market expansion.
The global Recombinant Type III Collagen market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Key Features:
The research report on the Recombinant Type III Collagen market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Recombinant Type III Collagen market.
Market Overview: The report provides a comprehensive overview of the Recombinant Type III Collagen market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Recombinant Type III Collagen Freeze-Dried Fiber, Complex Recombinant Type III Collagen Dressing), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Recombinant Type III Collagen market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Recombinant Type III Collagen market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Recombinant Type III Collagen market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Recombinant Type III Collagen market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Recombinant Type III Collagen market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Recombinant Type III Collagen market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Recombinant Type III Collagen, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Recombinant Type III Collagen market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Recombinant Type III Collagen market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Recombinant Type III Collagen Freeze-Dried Fiber
Complex Recombinant Type III Collagen Dressing
Recombinant Type III Collagen Gel
Other
Market segment by Application
Cartilage Repair Materials
Artificial Skin Manufacturing
Treatment Of Vaginal Disorders
Scar Prevention
Other
Global Recombinant Type III Collagen Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Novus Biologicals
Evonik Industries
Advanced BioMatrix
SNIME
Shanxi Jinbo Bio-Pharmaceutical
R&D Systems
BAHE
Harbin Fuerjia Technology
Beijing Duomeikang Medical Science and Technology
Yangzhou Meirui Biology
Outline of Major Chapters:
Chapter 1: Introduces the definition of Recombinant Type III Collagen, market overview.
Chapter 2: Global Recombinant Type III Collagen market size in revenue and volume.
Chapter 3: Detailed analysis of Recombinant Type III Collagen manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Recombinant Type III Collagen in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Recombinant Type III Collagen capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Recombinant Type III Collagen Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Recombinant Type III Collagen Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Recombinant Type III Collagen Overall Market Size
2.1 Global Recombinant Type III Collagen Market Size: 2022 VS 2029
2.2 Global Recombinant Type III Collagen Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Recombinant Type III Collagen Sales: 2018-2029
3 Company Landscape
3.1 Top Recombinant Type III Collagen Players in Global Market
3.2 Top Global Recombinant Type III Collagen Companies Ranked by Revenue
3.3 Global Recombinant Type III Collagen Revenue by Companies
3.4 Global Recombinant Type III Collagen Sales by Companies
3.5 Global Recombinant Type III Collagen Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Recombinant Type III Collagen Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Recombinant Type III Collagen Product Type
3.8 Tier 1, Tier 2 and Tier 3 Recombinant Type III Collagen Players in Global Market
3.8.1 List of Global Tier 1 Recombinant Type III Collagen Companies
3.8.2 List of Global Tier 2 and Tier 3 Recombinant Type III Collagen Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Recombinant Type III Collagen Market Size Markets, 2022 & 2029
4.1.2 Recombinant Type III Collagen Freeze-Dried Fiber
4.1.3 Complex Recombinant Type III Collagen Dressing
4.1.4 Recombinant Type III Collagen Gel
4.1.5 Other
4.2 By Type – Global Recombinant Type III Collagen Revenue & Forecasts
4.2.1 By Type – Global Recombinant Type III Collagen Revenue, 2018-2023
4.2.2 By Type – Global Recombinant Type III Collagen Revenue, 2024-2029
4.2.3 By Type – Global Recombinant Type III Collagen Revenue Market Share, 2018-2029
4.3 By Type – Global Recombinant Type III Collagen Sales & Forecasts
4.3.1 By Type – Global Recombinant Type III Collagen Sales, 2018-2023
4.3.2 By Type – Global Recombinant Type III Collagen Sales, 2024-2029
4.3.3 By Type – Global Recombinant Type III Collagen Sales Market Share, 2018-2029
4.4 By Type – Global Recombinant Type III Collagen Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Recombinant Type III Collagen Market Size, 2022 & 2029
5.1.2 Cartilage Repair Materials
5.1.3 Artificial Skin Manufacturing
5.1.4 Treatment Of Vaginal Disorders
5.1.5 Scar Prevention
5.1.6 Other
5.2 By Application – Global Recombinant Type III Collagen Revenue & Forecasts
5.2.1 By Application – Global Recombinant Type III Collagen Revenue, 2018-2023
5.2.2 By Application – Global Recombinant Type III Collagen Revenue, 2024-2029
5.2.3 By Application – Global Recombinant Type III Collagen Revenue Market Share, 2018-2029
5.3 By Application – Global Recombinant Type III Collagen Sales & Forecasts
5.3.1 By Application – Global Recombinant Type III Collagen Sales, 2018-2023
5.3.2 By Application – Global Recombinant Type III Collagen Sales, 2024-2029
5.3.3 By Application – Global Recombinant Type III Collagen Sales Market Share, 2018-2029
5.4 By Application – Global Recombinant Type III Collagen Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Recombinant Type III Collagen Market Size, 2022 & 2029
6.2 By Region – Global Recombinant Type III Collagen Revenue & Forecasts
6.2.1 By Region – Global Recombinant Type III Collagen Revenue, 2018-2023
6.2.2 By Region – Global Recombinant Type III Collagen Revenue, 2024-2029
6.2.3 By Region – Global Recombinant Type III Collagen Revenue Market Share, 2018-2029
6.3 By Region – Global Recombinant Type III Collagen Sales & Forecasts
6.3.1 By Region – Global Recombinant Type III Collagen Sales, 2018-2023
6.3.2 By Region – Global Recombinant Type III Collagen Sales, 2024-2029
6.3.3 By Region – Global Recombinant Type III Collagen Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Recombinant Type III Collagen Revenue, 2018-2029
6.4.2 By Country – North America Recombinant Type III Collagen Sales, 2018-2029
6.4.3 US Recombinant Type III Collagen Market Size, 2018-2029
6.4.4 Canada Recombinant Type III Collagen Market Size, 2018-2029
6.4.5 Mexico Recombinant Type III Collagen Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Recombinant Type III Collagen Revenue, 2018-2029
6.5.2 By Country – Europe Recombinant Type III Collagen Sales, 2018-2029
6.5.3 Germany Recombinant Type III Collagen Market Size, 2018-2029
6.5.4 France Recombinant Type III Collagen Market Size, 2018-2029
6.5.5 U.K. Recombinant Type III Collagen Market Size, 2018-2029
6.5.6 Italy Recombinant Type III Collagen Market Size, 2018-2029
6.5.7 Russia Recombinant Type III Collagen Market Size, 2018-2029
6.5.8 Nordic Countries Recombinant Type III Collagen Market Size, 2018-2029
6.5.9 Benelux Recombinant Type III Collagen Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Recombinant Type III Collagen Revenue, 2018-2029
6.6.2 By Region – Asia Recombinant Type III Collagen Sales, 2018-2029
6.6.3 China Recombinant Type III Collagen Market Size, 2018-2029
6.6.4 Japan Recombinant Type III Collagen Market Size, 2018-2029
6.6.5 South Korea Recombinant Type III Collagen Market Size, 2018-2029
6.6.6 Southeast Asia Recombinant Type III Collagen Market Size, 2018-2029
6.6.7 India Recombinant Type III Collagen Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Recombinant Type III Collagen Revenue, 2018-2029
6.7.2 By Country – South America Recombinant Type III Collagen Sales, 2018-2029
6.7.3 Brazil Recombinant Type III Collagen Market Size, 2018-2029
6.7.4 Argentina Recombinant Type III Collagen Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Recombinant Type III Collagen Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Recombinant Type III Collagen Sales, 2018-2029
6.8.3 Turkey Recombinant Type III Collagen Market Size, 2018-2029
6.8.4 Israel Recombinant Type III Collagen Market Size, 2018-2029
6.8.5 Saudi Arabia Recombinant Type III Collagen Market Size, 2018-2029
6.8.6 UAE Recombinant Type III Collagen Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Novus Biologicals
7.1.1 Novus Biologicals Company Summary
7.1.2 Novus Biologicals Business Overview
7.1.3 Novus Biologicals Recombinant Type III Collagen Major Product Offerings
7.1.4 Novus Biologicals Recombinant Type III Collagen Sales and Revenue in Global (2018-2023)
7.1.5 Novus Biologicals Key News & Latest Developments
7.2 Evonik Industries
7.2.1 Evonik Industries Company Summary
7.2.2 Evonik Industries Business Overview
7.2.3 Evonik Industries Recombinant Type III Collagen Major Product Offerings
7.2.4 Evonik Industries Recombinant Type III Collagen Sales and Revenue in Global (2018-2023)
7.2.5 Evonik Industries Key News & Latest Developments
7.3 Advanced BioMatrix
7.3.1 Advanced BioMatrix Company Summary
7.3.2 Advanced BioMatrix Business Overview
7.3.3 Advanced BioMatrix Recombinant Type III Collagen Major Product Offerings
7.3.4 Advanced BioMatrix Recombinant Type III Collagen Sales and Revenue in Global (2018-2023)
7.3.5 Advanced BioMatrix Key News & Latest Developments
7.4 SNIME
7.4.1 SNIME Company Summary
7.4.2 SNIME Business Overview
7.4.3 SNIME Recombinant Type III Collagen Major Product Offerings
7.4.4 SNIME Recombinant Type III Collagen Sales and Revenue in Global (2018-2023)
7.4.5 SNIME Key News & Latest Developments
7.5 Shanxi Jinbo Bio-Pharmaceutical
7.5.1 Shanxi Jinbo Bio-Pharmaceutical Company Summary
7.5.2 Shanxi Jinbo Bio-Pharmaceutical Business Overview
7.5.3 Shanxi Jinbo Bio-Pharmaceutical Recombinant Type III Collagen Major Product Offerings
7.5.4 Shanxi Jinbo Bio-Pharmaceutical Recombinant Type III Collagen Sales and Revenue in Global (2018-2023)
7.5.5 Shanxi Jinbo Bio-Pharmaceutical Key News & Latest Developments
7.6 R&D Systems
7.6.1 R&D Systems Company Summary
7.6.2 R&D Systems Business Overview
7.6.3 R&D Systems Recombinant Type III Collagen Major Product Offerings
7.6.4 R&D Systems Recombinant Type III Collagen Sales and Revenue in Global (2018-2023)
7.6.5 R&D Systems Key News & Latest Developments
7.7 BAHE
7.7.1 BAHE Company Summary
7.7.2 BAHE Business Overview
7.7.3 BAHE Recombinant Type III Collagen Major Product Offerings
7.7.4 BAHE Recombinant Type III Collagen Sales and Revenue in Global (2018-2023)
7.7.5 BAHE Key News & Latest Developments
7.8 Harbin Fuerjia Technology
7.8.1 Harbin Fuerjia Technology Company Summary
7.8.2 Harbin Fuerjia Technology Business Overview
7.8.3 Harbin Fuerjia Technology Recombinant Type III Collagen Major Product Offerings
7.8.4 Harbin Fuerjia Technology Recombinant Type III Collagen Sales and Revenue in Global (2018-2023)
7.8.5 Harbin Fuerjia Technology Key News & Latest Developments
7.9 Beijing Duomeikang Medical Science and Technology
7.9.1 Beijing Duomeikang Medical Science and Technology Company Summary
7.9.2 Beijing Duomeikang Medical Science and Technology Business Overview
7.9.3 Beijing Duomeikang Medical Science and Technology Recombinant Type III Collagen Major Product Offerings
7.9.4 Beijing Duomeikang Medical Science and Technology Recombinant Type III Collagen Sales and Revenue in Global (2018-2023)
7.9.5 Beijing Duomeikang Medical Science and Technology Key News & Latest Developments
7.10 Yangzhou Meirui Biology
7.10.1 Yangzhou Meirui Biology Company Summary
7.10.2 Yangzhou Meirui Biology Business Overview
7.10.3 Yangzhou Meirui Biology Recombinant Type III Collagen Major Product Offerings
7.10.4 Yangzhou Meirui Biology Recombinant Type III Collagen Sales and Revenue in Global (2018-2023)
7.10.5 Yangzhou Meirui Biology Key News & Latest Developments
8 Global Recombinant Type III Collagen Production Capacity, Analysis
8.1 Global Recombinant Type III Collagen Production Capacity, 2018-2029
8.2 Recombinant Type III Collagen Production Capacity of Key Manufacturers in Global Market
8.3 Global Recombinant Type III Collagen Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Recombinant Type III Collagen Supply Chain Analysis
10.1 Recombinant Type III Collagen Industry Value Chain
10.2 Recombinant Type III Collagen Upstream Market
10.3 Recombinant Type III Collagen Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Recombinant Type III Collagen Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
